About Conference
6th Global Cancer Summit - 2024 (GCS-2024) with the theme "LIVING WITH CANCER IN THE 21ST CENTURY" on 8th December 2024 at J.N.Tata Auditorium, Indian Institute of Science (IISc), Bangalore.
The Conference is being jointly organized by BioGenesis Health Cluster, Global Cancer Foundation and Indian Council of Medical Research, Government of India. The 6th Global Cancer Summit - 2024 is the Central Congress, where Cancer Researchers from over 60 countries, in different stages of their careers, come together to discuss the latest developments in Cancer Research and Treatments.
The Focus of the Conference is on Cancer Stem Cells, Cancer Basic & Applied Research Tumor, Anti-Cancer Drug Discovery, Clinical Oncology and Personalized Cancer Medicine. It will give us novel insight into the complexity of the connections between Cancer and Metabolism &Immune Checkpoints, to deliver an outstanding program with the right balance of clinical relevance, which covers the entire spectrum of practice issues in Cancer Research and Treatments.
Global Cancer Summit will host the Award Ceremony for the prestigious Edward Kennedy Memorial Award- 2021 in the areas of Experimental, Translational and Clinical Cancer Research, respectively.
Evaluation Report of the II Global Cancer Summit - 2017, Kuala Lumpur, Malaysia and Global Cancer Summit - 2015, Bengaluru, India
II Global Cancer Summit - 2017, Kuala Lumpur, Malaysia and Global Cancer Summit - 2015, Bengaluru, India has hosted more than 1500 delegates from more than 100 countries. With 25 expert keynote speakers, 70 national & international speakers, more than 300 poster presentations, 200 oral presentations, 27 exhibitors, and 15 sponsors, the Global Cancer Summit - 2015 was a grand success. The conference had a mix of delegates including oncologists, basic researchers, care providers, nurses, industrialists, cancer survivors and general public. The conference hosted about 46% of the delegates from educational institutions, 3.3 % from public sector, 7.7% from industry and 43% from research institutions. About 22.8% of delegates from India, 9.0% from Norway, 8.4% from Netherlands, 7.6% from UK, 7.3% from Denmark, 2.7% from USA, 2.5 % from Sweden, 2.5% from Poland, 2.4% Finland, 2.3% from Switzerland, 2.1% from France, 1.9% from Spain, 1.8% from Belgium, 1.1% from South Africa, 1.7% from Canada and 24.6 % from rest of the nation’s attending the conference.
In the II Global Cancer Summit - 2017, Kuala Lumpur, Malaysia and Global Cancer Summit - 2015, Bengaluru, India delegate survey, 98% of the respondents mentioned they would recommend the event to a colleague. This result emphasises the high level of satisfaction that the event generated amongst its participants. Amongst the listed Conference highlights, the high quality of the plenary sessions and their presenting speakers were the clear winners, followed by some specific experts who have inspired their audience. The vibrant and dynamic atmosphere of the Global Cancer Summit also enthused largely through its ability to facilitate connections and networking opportunities. The social event such as the Gala Dinner hosted by the UKTI British High Commission at Howard Johnson Hotel was also one of the highlights.